Endoplasmic reticulum stress: molecular mechanism and therapeutic targets

X Chen, C Shi, M He, S Xiong, X Xia - Signal transduction and targeted …, 2023 - nature.com
The endoplasmic reticulum (ER) functions as a quality-control organelle for protein
homeostasis, or “proteostasis”. The protein quality control systems involve ER-associated …

Advances in the clinical management of uveal melanoma

RD Carvajal, JJ Sacco, MJ Jager… - Nature Reviews …, 2023 - nature.com
Melanomas arising in the uveal tract of the eye are a rare form of the disease with a biology
and clinical phenotype distinct from their more common cutaneous counterparts. Treatment …

Nivolumab and ipilimumab in metastatic uveal melanoma: results from a single-arm phase II study

MS Pelster, SK Gruschkus, R Bassett… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE Metastatic uveal melanoma has poor overall survival (OS) and no approved
systemic therapy options. Studies of single-agent immunotherapy regimens have shown …

[HTML][HTML] Metastatic uveal melanoma: The final frontier

ES Rantala, MM Hernberg, S Piperno-Neumann… - Progress in Retinal and …, 2022 - Elsevier
Abstract Treatment of primary intraocular uveal melanoma has developed considerably, its
driver genes are largely unraveled, and the ways to assess its risk for metastases are very …

Uveal melanoma: epidemiology, etiology, and treatment of primary disease

BA Krantz, N Dave, KM Komatsubara… - Clinical …, 2017 - Taylor & Francis
Uveal melanoma (UM) is the most common intraocular malignancy and arises from
melanocytes in the iris, ciliary body, or choroid. Early diagnosis and local treatment is …

[HTML][HTML] Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) …

L Khoja, EG Atenafu, S Suciu, S Leyvraz, T Sato… - Annals of …, 2019 - Elsevier
Background Despite the completion of numerous phase II studies, a standard of care
treatment has yet to be defined for metastatic uveal melanoma (mUM). To determine …

Clinical outcomes in metastatic uveal melanoma treated with PD‐1 and PD‐L1 antibodies

AP Algazi, KK Tsai, AN Shoushtari, RR Munhoz… - Cancer, 2016 - Wiley Online Library
BACKGROUND Antibodies inhibiting the programmed death receptor 1 (PD‐1) have
demonstrated significant activity in the treatment of advanced cutaneous melanoma. The …

Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial

RD Carvajal, JA Sosman, JF Quevedo, MM Milhem… - Jama, 2014 - jamanetwork.com
Importance Uveal melanoma is characterized by mutations inGNAQandGNA11, resulting in
mitogen-activated protein kinase pathway activation. Objective To assess the efficacy of …

Uveal melanoma: estimating prognosis

S Kaliki, CL Shields, JA Shields - Indian journal of ophthalmology, 2015 - journals.lww.com
Uveal melanoma is the most common primary malignant tumor of the eye in adults,
predominantly found in Caucasians. Local tumor control of uveal melanoma is excellent, yet …

The biology of uveal melanoma

A Amaro, R Gangemi, F Piaggio, G Angelini… - Cancer and Metastasis …, 2017 - Springer
Uveal melanoma (UM), a rare cancer of the eye, is distinct from cutaneous melanoma by its
etiology, the mutation frequency and profile, and its clinical behavior including resistance to …